Antibody therapy as a future treatment option for Ebola virus infection

ISSN： 1746-0794

Source： Future Virology, Vol.2, Iss.6, 2007-11, pp. : 607-614

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Drug Targets and Antiviral Molecules for Treatment of Ebola Virus Infection

Current Topics in Medicinal Chemistry, Vol. 17, Iss. 3, 2017-01 ,pp. : 361-370

Bentham Science Publishers

Access to resources Recommend Favorite

NCRNA Combined Therapy as Future Treatment Option for Cancer

Current Pharmaceutical Design, Vol. 20, Iss. 42, 2014-12 ,pp. : 6565-6574

Bentham Science Publishers

Access to resources Recommend Favorite

Ebola Virus: Current and Future Perspectives

Infectious Disorders - Drug Targets (Formerly Current Drug Targets - Infectious Disorders), Vol. 15, Iss. 1, 2015-03 ,pp. : 20-31

Bentham Science Publishers

Access to resources Recommend Favorite

NAPc2 prolongs survival in Ebola virus infection

Inpharma, Vol. 1, Iss. 1418, 2003-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Does mitochondrial dysfunction during antiretroviral therapy in human immunodeficiency virus infection suggest antioxidant supplementation as a beneficial option?

By Gil Lizette Pérez Daniel Tápanes Rolando Pérez Jorge Grune Tilman

Redox Report, Vol. 10, Iss. 3, 2005-06 ,pp. : 113-119

Maney Publishing

Access to resources Recommend Favorite